Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01787539

The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer (STOPEROPCHEM)

The Role of Postoperative Chemotherapy Cycles in the Combined Modality Therapy of Gastric Cancer With Perioperative Chemotherapy and Surgery in Pathological Responders

Sponsor: Medical University of Lublin

Conditions Gastric Cancer

Interventions Postoperative Chemotherapy

Updated 5 times since 2017 Last updated: Feb 6, 2013 Started: Feb 28, 2013 Primary completion: Feb 28, 2017 Completion: Feb 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Gastric Cancer, this trial is ongoing. The trial is conducted by Medical University of Lublin and has accumulated 5 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Mar 2022 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Recruiting PHASE2_PHASE3
Jan 2017 — Jan 2021 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Lublin
St Johns' Oncology Center in Lublin

Data source: Medical University of Lublin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lublin, Poland